腹腔恶性血管周上皮样细胞肿瘤合并转移性肝癌一例并文献学习
A Case of Malignant Perivascular Epithelioid Cell Tumor in the Abdominal Cavity Combined with Metastatic Liver Cancer and Literature Review
DOI: 10.12677/acm.2025.15123470, PDF,    科研立项经费支持
作者: 谢绍文, 魏 东*, 唐 波, 邹仁超, 杨欣怡:昆明医科大学第二附属医院肝胆胰外科四病区,云南 昆明
关键词: 腹腔肿瘤血管周上皮样细胞肿瘤病理Abdominal Tumor Perivascular Epithelioid Cell Tumor Pathology
摘要: 血管周上皮样细胞肿瘤(PEComa)是起源于间质的罕见肿瘤,大多数良性,少数呈恶性。血管周上皮样细胞肿瘤多发于子宫、膀胱。血管周上皮样细胞肿瘤临床表现多无特异性,大多经CT等检查发现。本次分享的肾血管周上皮样细胞肿瘤为恶性,经开腹腹腔巨大肿瘤切除 + 左肾切除 + 肝左外叶切除 + 右肝部分切除 + 肝脏微波射频消融后病检确诊。
Abstract: Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal-origin tumor, most of which are benign, with a few presenting as malignant. PEComas most frequently occur in the uterus and bladder. The clinical manifestations of PEComa are mostly nonspecific and are often discovered through imaging such as CT scans. The renal PEComa shared in this case was malignant and was pathologically confirmed after open abdominal surgery involving resection of a large abdominal tumor, left lateral hepatectomy, partial resection of the right liver, and microwave radiofrequency ablation of the liver.
文章引用:谢绍文, 魏东, 唐波, 邹仁超, 杨欣怡. 腹腔恶性血管周上皮样细胞肿瘤合并转移性肝癌一例并文献学习[J]. 临床医学进展, 2025, 15(12): 779-785. https://doi.org/10.12677/acm.2025.15123470

参考文献

[1] Gaffey, M.J., Mills, S.E., Zarbo, R.J. and Weiss, L.M. (1992) Authorʼs Reply. The American Journal of Surgical Pathology, 16, 308. [Google Scholar] [CrossRef
[2] Zamboni, G., Pea, M., Martignoni, G., Zancanaro, C., Faccioli, G., Gilioli, E., et al. (1996) Clear Cell “Sugar” Tumor of the Pancreas: A Novel Member of the Family of Lesions Characterized by the Presence of Perivascular Epithelioid Cells. The American Journal of Surgical Pathology, 20, 722-730. [Google Scholar] [CrossRef] [PubMed]
[3] Sobiborowicz, A., Czarnecka, A.M., Szumera-Ciećkiewicz, A., Rutkowski, P. and Świtaj, T. (2020) Diagnosis and Treatment of Malignant PEComa Tumours. Oncology in Clinical Practice, 16, 22-33. [Google Scholar] [CrossRef
[4] 宣兰兰, 魏建国, 刘红刚. 血管周上皮样细胞肿瘤的病理诊断及新进展[J]. 中华病理学杂志, 2021, 50(3): 282-287.
[5] Sholan, R., Aliyev, R., Sultan, M., Almazkhanli, A., Karim, S. and Gasimov, J. (2025) Renal PEComa in a Young Male: A Case Report and Insights from the Literature. Urology Case Reports, 58, Article ID: 102890. [Google Scholar] [CrossRef] [PubMed]
[6] Du, H., Zhou, J., Xu, L., Yang, C., Zhang, L. and Liang, C. (2016) Pigmented Perivascular Epithelioid Cell Tumor (PEComa) Arising from Kidney: A Case Report. Medicine, 95, e5248. [Google Scholar] [CrossRef] [PubMed]
[7] Folpe, A.L., Mentzel, T., Lehr, H., Fisher, C., Balzer, B.L. and Weiss, S.W. (2005) Perivascular Epithelioid Cell Neoplasms of Soft Tissue and Gynecologic Origin: A Clinicopathologic Study of 26 Cases and Review of the Literature. American Journal of Surgical Pathology, 29, 1558-1575. [Google Scholar] [CrossRef] [PubMed]
[8] 林丽丹, 胡雅诺, 邱思凡, 等. 肾乏脂型血管平滑肌脂肪瘤与非透明细胞肾癌的CT鉴别诊断[J]. 中国CT和MRI杂志, 2024, 22(1): 107-109, 113.
[9] Zhao, Y., Bui, M.M., Spiess, P.E. and Dhillon, J. (2014) Sclerosing PEComa of the Kidney: Clinicopathologic Analysis of 2 Cases and Review of the Literature. Clinical Genitourinary Cancer, 12, e229-e232. [Google Scholar] [CrossRef] [PubMed]
[10] Martignoni, G., Pea, M., Zampini, C., Brunelli, M., Segala, D., Zamboni, G., et al. (2015) PEComas of the Kidney and of the Genitourinary Tract. Seminars in Diagnostic Pathology, 32, 140-159. [Google Scholar] [CrossRef] [PubMed]
[11] Qin, W., Bajaj, V., Malinowska, I., Lu, X., MacConaill, L., Wu, C., et al. (2011) Angiomyolipoma Have Common Mutations in TSC2 but No Other Common Genetic Events. PLOS ONE, 6, e24919. [Google Scholar] [CrossRef] [PubMed]
[12] Sanfilippo, R., Jones, R.L., Blay, J., Le Cesne, A., Provenzano, S., Antoniou, G., et al. (2019) Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas). Clinical Cancer Research, 25, 5295-5300. [Google Scholar] [CrossRef] [PubMed]
[13] Wagner, A.J., Malinowska-Kolodziej, I., Morgan, J.A., Qin, W., Fletcher, C.D.M., Vena, N., et al. (2010) Clinical Activity of mTOR Inhibition with Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of Mtorc1 in Tumors. Journal of Clinical Oncology, 28, 835-840. [Google Scholar] [CrossRef] [PubMed]